| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | OpenSpace | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $201.03M | Series D | 8/9/2022 | $111.3M | $912.78M | $8.89 | PSP Partners, BlackRock, Alpaca VC, Fischer Homes, Harmonic Growth Partners, Mirae Asset, Sino Group, Alkeon Capital Management, GreenPoint Partners, JLL Spark, Lux Capital, Menlo Ventures, Navitas Capital, Nine Four Ventures, Taronga Ventures | ||||
 | Paige | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $247.3M | Series C-1 | 3/2/2023 | $19.5M | $656.14M | $25.74 | Undisclosed Investors | ||||
 | Prizeout | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $108.83M | Series C-1 | 1/21/2025 | $60M | $716.38M | $42.92 | Undisclosed Investors | ||||
 | Proof | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $225.61M | Series E | 10/27/2025 | $4.2M | $986.73M | $19.40 | Undisclosed Investors | ||||
 | Rhino.ai | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $50M | Series A | 1/21/2025 | $50M | $513.59M | $31.39 | Koch Disruptive Technologies | ||||
 | ScienceLogic | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $126.87M | Series E | 2/26/2021 | $62.96M | $837.08M | $9.91 | Silver Lake Waterman, Goldman Sachs, Intel Capital, NewView Capital | ||||
 | Sense Talent Labs | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $89.97M | Series D | 12/6/2021 | $50M | $500.37M | $13.43 | SoftBank | ||||
 | Sionna Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $331.32M | Series C | 3/6/2024 | $181.86M | $523.7M | $9.76 | Enavate Sciences, Viking Global Investors, Perceptive Advisors, RA Capital, TPG, Atlas Venture, Cystic Fibrosis Foundation, T. Rowe Price, Qatar Investment Authority, OrbiMed | ||||
 | Sprout Social | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $96.75M | Series D | 12/20/2018 | $40.5M | $809.05M | $18.61 | Goldman Sachs, New Enterprise Associates, The Future Fund | ||||
 | Strata Oncology | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $128.35M | Series A-3 | 7/28/2021 | $84.92M | $561.3M | $34.88 | Wellington Management, Cormorant Asset Management, Monashee Investment Management, Highside Capital Management, Pfizer Ventures, Merck Global Health Innovation Fund, Arboretum Ventures, Deerfield Management, Baird Capital, Renaissance Venture Capital | ||||
 | The Honest Company | Consumer & Lifestyle Home Products | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $343.87M | Series F | 6/11/2018 | $50M | $911.37M | $9.80 | Undisclosed investors | ||||
 | ThirdLove | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $72.16M | Series B-2 | 2/26/2019 | $40M | $670.66M | $7.41 | L. Catterton, Allen & Company, Anne Wojcicki, Susan Wojcicki, Katie Couric, Nancy Peretsman, Tim Armostrong, Jeff Keswin, Michael Zeisser, Felicis Ventures, Valor Equity, Andreessen Horowitz, NEA, Yuri Milner, Keith Rabois | ||||
 | VSCO | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $91.34M | Series B | 4/24/2015 | $51.34M | $630.71M | $3.42 | Obvious Ventures, Goldcrest Investments, Glynn Capital Management, Betaworks Ventures, Accel Partners | ||||
 | Wonolo | Consumer & Lifestyle Other Consumer & Lifestyle | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $214.86M | Series D | 10/19/2021 | $96M | $500.29M | $4.50 | 137 Ventures, G2 Venture Partners, Franklin Templeton, Leeds Illuminate | ||||
 | 98point6 | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $267.22M | Series E | 10/15/2020 | $134.21M | $548.43M | $6.59 | L Catterton, Activant Capital, Goldman Sachs | ||||
 | Alma | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $441.06M | Series D | 8/25/2022 | $130M | $788.56M | $17.52 | Thoma Bravo, Cigna Ventures, Insight Partners, Optum Ventures, Tusk Venture Partners, Primary Venture Partners, Sound Ventures | ||||
 | Articul8 AI | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $109.14M | Series B-1 | 6/16/2026 | $46M | $570M | $19.46 | Adara Ventures, Aditya Birla Ventures, NXC, Dragon Global | ||||
 | Athelas | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $365.02M | Series B-2 | 10/3/2023 | $60M | $969.5M | $103.96 | Undisclosed Investors | ||||
 | Candid Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $370M | Series B | 9/9/2024 | $190.26M | $660.51M | $1.20 | Venrock, Fairmount Partners, TCG Crossover Management, venBio Partners, Foresite Capital, Third Rock Ventures, Fidelity, Samsara BioCapital, Qiming Venture Partners, OrbiMed, Boxer Capital, Redmile Group, Vida Ventures, Two River, Franklin Templeton, LifeSci Venture Partners, Mirae Asset Capital Life Science, Polaris Partners, Soleus Capital | ||||
 | Census | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $83.38M | Series B | 2/9/2022 | $63M | $630.01M | $4.30 | Tiger Global Management, Sequoia, Andreessen Horowitz | ||||
 | CScale | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $188.35M | Series C | 9/30/2026 | $145M | $937M | $19.14 | Atreides Management, Valor Equity Partners, Premji Invest, Sutter Hill Ventures, Maverick Silicon, NVIDIA, Intel | ||||
 | Cyber Resilience | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $605.12M | Series D | 8/7/2023 | $100M | $942.91M | $11.95 | Intact Ventures, Lightspeed Venture Partners, General Catalyst, Founders Fund | ||||
 | Databook | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $71.99M | Series B | 2/14/2022 | $50M | $550.39M | $5.09 | Bessmer Venture Partners, DFJ Growth, Threshold Ventures, M12, Salesforce Ventures, Haystack | ||||
 | Embark Trucks | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $117.61M | Series C | 9/25/2019 | $70M | $503.07M | $3.50 | Tiger Global, Sequoia Capital, DCVC, Y Combinator, SV Angel, Maven Ventures, OMERS Ventures, Mubadala Ventures, Garage Capital, Transform VC, Transpose Platform Management | ||||